Is tamoxifen associated with an increased risk for thromboembolic complications in patients undergoing microvascular breast reconstruction? [Ist die Einnahme von Tamoxifen zum Zeitpunkt der mikrovaskulären Brustrekonstruktion mit einer erhöhten Rate an thrombembolischen Komplikationen assoziiert?]

Is tamoxifen associated with an increased risk for thromboembolic complications in patients undergoing microvascular breast reconstruction? [Ist die Einnahme von Tamoxifen zum Zeitpunkt der mikrovaskulären Brustrekonstruktion mit einer erhöhten Rate an thrombembolischen Komplikationen assoziiert?]

[english] Introduction: Tamoxifen is associated with a twofold increased risk of thromboembolic events. Third generation aromatase inhibitors (AIs), such as letrozole, anastrozole, and exemestane have therefore replaced tamoxifen in the adjuvant therapy of hormone receptor-positive breast cancer. A...

Full description

Bibliographic Details
Main Authors: Krämer, Robert, Branski, Ludwik, Betzler, Christopher, Radtke, Christine, Jokuszies, Andreas, Vogt, Peter M.
Format: Article
Language:deu
Published: German Medical Science GMS Publishing House 2013-02-01
Series:GMS German Medical Science
Subjects:
Tamoxifen
breast cancer
adjuvant therapy
microvascular breast reconstruction
Online Access:http://www.egms.de/static/en/journals/gms/2013-11/000173.shtml

Internet

http://www.egms.de/static/en/journals/gms/2013-11/000173.shtml

Similar Items